To the Editor In their systematic review of the Lariat (SentreHeart Inc) left atrial appendage (LAA) ligation system, Chatterjee et al1 question the safety classification of the device, citing adverse events recorded in the US Food and Drug Administration’s (FDA) Manufacturer and User Facility Device Experience (MAUDE) database.1